Health Sector Faces Multiple Crises as Maternity Units, New Virus and Alzheimer's Research Dominate Headlines

Oct 22 – A wave of significant health developments emerged Thursday, spanning a maternity care emergency threatening dozens of units in England, the first human detection of a livestock virus in France, and a new clinical trial targeting Alzheimer's disease with repurposed drugs.

Up to 20 maternity units in England could close due to staff shortages, rising rates of caesarean sections and years of unresolved safety concerns, according to a report by The Guardian. The crisis has already forced the suspension of maternity services at North Devon District Hospital in Barnstaple, one of the most remote hospitals in the United Kingdom, where emergency department doctors received crash training in delivering babies this past summer. Their training covered complications including shoulder dystocia, postpartum haemorrhage and neonatal collapse. NHS trusts across the country are struggling to recruit sufficient staff to safely deliver babies, and other remote hospitals are expected to follow North Devon's lead, The Guardian reported.

In France, health officials confirmed the first known human case of Shamonda virus, a pathogen typically found in livestock. According to The Guardian, a man in France contracted the bunyavirus, which is spread through bites from infected midges, and investigations are under way to determine whether the virus contributed to his death in early October. The BBC reported the case was identified by officials who are now working to establish the full circumstances. In animals such as cattle, sheep and goats, Shamonda virus can cause diarrhoea, loss of appetite, reduced milk yield and reproductive complications, according to the Austrian Agency for Health and Food Safety, as cited by The Guardian.

In a separate development, diabetes and attention deficit hyperactivity disorder medications are to be tested simultaneously on Alzheimer's patients in a new clinical study, the BBC reported. Researchers hope that testing the drugs concurrently will accelerate the search for new treatments for the most common form of dementia. The study represents a shift in approach, using existing approved medications to explore potential benefits for Alzheimer's patients rather than developing entirely new compounds.

Pope Leo, 71, will not require further treatment following lung cancer surgery performed on Oct. 13, his doctors announced, according to both The Guardian and the BBC. The pontiff had the lower lobe of his right lung removed and was diagnosed with lung adenocarcinoma. Test results confirmed the tumour was localised and had not spread, though questions remain over whether he will proceed with a planned trip to South America next month, The Guardian reported.

The convergence of these developments underscores the breadth of pressures currently facing health systems and medical researchers. From structural failures in maternity care to emerging infectious disease threats and the ongoing search for dementia treatments, health authorities in Europe and beyond are confronting challenges that demand urgent and coordinated responses.